Intimation regarding completion of term of Independent Director of Mr. Mopperthy Sudheer
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals has informed BSE that Mr. Mopperthy Sudheer (DIN: 00404917) has completed his term as an Independent Director and ceased to hold office from the close of business hours on January 5, 2026. As a result, he also stepped down from the Audit Committee and the Nomination & Remuneration Committee. The change is being disclosed under Regulation 30 of the SEBI Listing Regulations. No replacement appointment has been mentioned in this filing.
This is a routine completion of a director's tenure and is unlikely to have any material impact on the stock price. Investors may want to watch for a follow-up announcement regarding the appointment of a new Independent Director to maintain board composition and committee requirements.